Serum procalcitonin and C-reactive protein kinetics as indicators of treatment outcome in hospitalized patients with community-acquired pneumonia

Creative Commons License

TAŞBAKAN M. S., GÜNDÜZ C., SAYINER A., ÇİLLİ A., Celenk Karaboga B., ŞAKAR COŞKUN A., ...Daha Fazla

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.46, sa.5, ss.1422-1427, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 46 Sayı: 5
  • Basım Tarihi: 2016
  • Doi Numarası: 10.3906/sag-1507-20
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.1422-1427
  • Anahtar Kelimeler: Procalcitonin, C-reactive protein, treatment, pneumonia, TREATMENT FAILURE, BIOMARKERS, MANAGEMENT, MORTALITY, RISK
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Background/aim: There has been growing interest in the use of serum procalcitonin (PCT) and C-reactive protein (CRP) in patients with community-acquired pneumonia (CAP). The aim of this study was to investigate whether an assessment of fever, leukocyte count, and serum CRP and PCT levels on admission and during follow-up (day 3) provides any information about the clinical outcome in hospitalized patients with CAP.